Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients
Keyword(s):
Phase Ii
◽
2012 ◽
Vol 69
(6)
◽
pp. 1641-1645
◽
2015 ◽
Vol 51
◽
pp. S432
◽
2017 ◽
Vol 49
(3)
◽
pp. 706-716
◽
2012 ◽
Vol 9
(1)
◽
pp. 60-65
◽
2005 ◽
Vol 20
(6)
◽
pp. 966
◽
2006 ◽
Vol 103
(2)
◽
pp. 523-526
◽